(BLD) Topbuild - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US89055F1030
Stock: Insulation, Building Materials, Installation, Distribution
Total Rating 36
Risk 73
Buy Signal -1.38
| Risk 5d forecast | |
|---|---|
| Volatility | 40.8% |
| Relative Tail Risk | -7.11% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.32 |
| Alpha | -14.78 |
| Character TTM | |
|---|---|
| Beta | 1.707 |
| Beta Downside | 2.273 |
| Drawdowns 3y | |
|---|---|
| Max DD | 42.41% |
| CAGR/Max DD | 0.48 |
EPS (Earnings per Share)
Revenue
Description: BLD Topbuild March 05, 2026
TopBuild Corp. (BLD) installs and distributes insulation and other building materials. The company operates in two segments: Installation and Specialty Distribution. This dual approach is common in the building materials sector, allowing companies to capture both service and product revenue streams.
Product offerings include insulation, glass, windows, gutters, garage doors, fireplaces, and roofing. Installation services cover various insulation types, such as fiberglass batts, spray foam, and cellulose. The company also distributes building and mechanical insulation to residential, commercial, and industrial markets.
TopBuild serves a broad customer base, including single-family and multi-family homebuilders, commercial contractors, remodelers, and individual homeowners. The company also supplies insulation and other contractors. This diverse customer base mitigates reliance on any single market segment.
Operations span the United States and Canada through a network of installation branches and distribution centers. BLD was incorporated in 2015, having previously been Masco SpinCo Corp. Further detailed financial and operational data can be found on ValueRay.
Headlines to watch out for
- Residential construction starts impact insulation installation demand
- Commercial building activity drives specialty distribution sales
- Material cost fluctuations affect profit margins
- Interest rate hikes reduce new construction projects
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 521.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA -4.57 > 1.0 |
| NWC/Revenue: 14.60% < 20% (prev 15.61%; Δ -1.00% < -1%) |
| CFO/TA 0.11 > 3% & CFO 756.3m > Net Income 521.7m |
| Net Debt (2.97b) to EBITDA (976.7m): 3.04 < 3 |
| Current Ratio: 1.94 > 1.5 & < 3 |
| Outstanding Shares: last quarter (28.1m) vs 12m ago -4.58% < -2% |
| Gross Margin: 29.01% > 18% (prev 0.30%; Δ 2.87k% > 0.5%) |
| Asset Turnover: 94.32% > 50% (prev 112.6%; Δ -18.23% > 0%) |
| Interest Coverage Ratio: 7.78 > 6 (EBITDA TTM 976.7m / Interest Expense TTM 103.8m) |
Altman Z'' 4.25
| A: 0.12 (Total Current Assets 1.63b - Total Current Liabilities 844.8m) / Total Assets 6.73b |
| B: 0.52 (Retained Earnings 3.52b / Total Assets 6.73b) |
| C: 0.14 (EBIT TTM 807.4m / Avg Total Assets 5.73b) |
| D: 0.79 (Book Value of Equity 3.50b / Total Liabilities 4.42b) |
| Altman-Z'' Score: 4.25 = AA |
Beneish M -2.75
| DSRI: 1.17 (Receivables 894.4m/751.6m, Revenue 5.41b/5.33b) |
| GMI: 1.05 (GM 29.01% / 30.49%) |
| AQI: 1.19 (AQ_t 0.67 / AQ_t-1 0.57) |
| SGI: 1.01 (Revenue 5.41b / 5.33b) |
| TATA: -0.03 (NI 521.7m - CFO 756.3m) / TA 6.73b) |
| Beneish M-Score: -2.75 (Cap -4..+1) = A |
What is the price of BLD shares?
As of March 22, 2026, the stock is trading at USD 335.44 with a total of 629,912 shares traded.
Over the past week, the price has changed by -8.65%, over one month by -35.36%, over three months by -21.91% and over the past year by +9.42%.
Over the past week, the price has changed by -8.65%, over one month by -35.36%, over three months by -21.91% and over the past year by +9.42%.
Is BLD a buy, sell or hold?
Topbuild has received a consensus analysts rating of 4.17.
Therefore, it is recommended to buy BLD.
- StrongBuy: 6
- Buy: 2
- Hold: 4
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the BLD price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 498.1 | 48.5% |
| Analysts Target Price | 498.1 | 48.5% |
BLD Fundamental Data Overview March 20, 2026
P/E Trailing = 19.5659
P/E Forward = 19.9601
P/S = 1.8617
P/B = 4.3477
Revenue TTM = 5.41b USD
EBIT TTM = 807.4m USD
EBITDA TTM = 976.7m USD
Long Term Debt = 2.78b USD (from longTermDebt, last quarter)
Short Term Debt = 155.2m USD (from shortTermDebt, last quarter)
Debt = 3.15b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.97b USD (from netDebt column, last quarter)
Enterprise Value = 13.04b USD (10.07b + Debt 3.15b - CCE 184.7m)
Interest Coverage Ratio = 7.78 (Ebit TTM 807.4m / Interest Expense TTM 103.8m)
EV/FCF = 18.71x (Enterprise Value 13.04b / FCF TTM 696.9m)
FCF Yield = 5.35% (FCF TTM 696.9m / Enterprise Value 13.04b)
FCF Margin = 12.88% (FCF TTM 696.9m / Revenue TTM 5.41b)
Net Margin = 9.65% (Net Income TTM 521.7m / Revenue TTM 5.41b)
Gross Margin = 29.01% ((Revenue TTM 5.41b - Cost of Revenue TTM 3.84b) / Revenue TTM)
Gross Margin QoQ = 27.24% (prev 30.07%)
Tobins Q-Ratio = 1.94 (Enterprise Value 13.04b / Total Assets 6.73b)
Interest Expense / Debt = 1.21% (Interest Expense 38.2m / Debt 3.15b)
Taxrate = 27.17% (39.0m / 143.5m)
NOPAT = 588.0m (EBIT 807.4m * (1 - 27.17%))
Current Ratio = 1.94 (Total Current Assets 1.63b / Total Current Liabilities 844.8m)
Debt / Equity = 1.36 (Debt 3.15b / totalStockholderEquity, last quarter 2.32b)
Debt / EBITDA = 3.04 (Net Debt 2.97b / EBITDA 976.7m)
Debt / FCF = 4.26 (Net Debt 2.97b / FCF TTM 696.9m)
Total Stockholder Equity = 2.20b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.10% (Net Income 521.7m / Total Assets 6.73b)
RoE = 23.72% (Net Income TTM 521.7m / Total Stockholder Equity 2.20b)
RoCE = 16.20% (EBIT 807.4m / Capital Employed (Equity 2.20b + L.T.Debt 2.78b))
RoIC = 13.25% (NOPAT 588.0m / Invested Capital 4.44b)
WACC = 9.51% (E(10.07b)/V(13.22b) * Re(12.21%) + D(3.15b)/V(13.22b) * Rd(1.21%) * (1-Tc(0.27)))
Discount Rate = 12.21% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -5.95%
[DCF] Terminal Value 74.92% ; FCFF base≈700.8m ; Y1≈800.2m ; Y5≈1.10b
[DCF] Fair Price = 412.5 (EV 14.57b - Net Debt 2.97b = Equity 11.61b / Shares 28.1m; r=9.51% [WACC]; 5y FCF grow 16.58% → 2.90% )
EPS Correlation: 54.35 | EPS CAGR: 6.93% | SUE: -0.25 | # QB: 0
Revenue Correlation: 64.76 | Revenue CAGR: 6.60% | SUE: -0.29 | # QB: 0
EPS next Quarter (2026-06-30): EPS=4.82 | Chg7d=-0.027 | Chg30d=-0.679 | Revisions Net=-10 | Analysts=15
EPS current Year (2026-12-31): EPS=18.41 | Chg7d=-0.147 | Chg30d=-2.464 | Revisions Net=-11 | Growth EPS=-6.9% | Growth Revenue=+12.3%
EPS next Year (2027-12-31): EPS=21.30 | Chg7d=-0.178 | Chg30d=-2.351 | Revisions Net=-11 | Growth EPS=+15.7% | Growth Revenue=+4.3%
[Analyst] Revisions Ratio: -0.83 (1 Up / 11 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 7.1% (Discount Rate 12.2% - Earnings Yield 5.1%)
[Growth] Growth Spread = +12.3% (Analyst 19.4% - Implied 7.1%)
P/E Forward = 19.9601
P/S = 1.8617
P/B = 4.3477
Revenue TTM = 5.41b USD
EBIT TTM = 807.4m USD
EBITDA TTM = 976.7m USD
Long Term Debt = 2.78b USD (from longTermDebt, last quarter)
Short Term Debt = 155.2m USD (from shortTermDebt, last quarter)
Debt = 3.15b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 2.97b USD (from netDebt column, last quarter)
Enterprise Value = 13.04b USD (10.07b + Debt 3.15b - CCE 184.7m)
Interest Coverage Ratio = 7.78 (Ebit TTM 807.4m / Interest Expense TTM 103.8m)
EV/FCF = 18.71x (Enterprise Value 13.04b / FCF TTM 696.9m)
FCF Yield = 5.35% (FCF TTM 696.9m / Enterprise Value 13.04b)
FCF Margin = 12.88% (FCF TTM 696.9m / Revenue TTM 5.41b)
Net Margin = 9.65% (Net Income TTM 521.7m / Revenue TTM 5.41b)
Gross Margin = 29.01% ((Revenue TTM 5.41b - Cost of Revenue TTM 3.84b) / Revenue TTM)
Gross Margin QoQ = 27.24% (prev 30.07%)
Tobins Q-Ratio = 1.94 (Enterprise Value 13.04b / Total Assets 6.73b)
Interest Expense / Debt = 1.21% (Interest Expense 38.2m / Debt 3.15b)
Taxrate = 27.17% (39.0m / 143.5m)
NOPAT = 588.0m (EBIT 807.4m * (1 - 27.17%))
Current Ratio = 1.94 (Total Current Assets 1.63b / Total Current Liabilities 844.8m)
Debt / Equity = 1.36 (Debt 3.15b / totalStockholderEquity, last quarter 2.32b)
Debt / EBITDA = 3.04 (Net Debt 2.97b / EBITDA 976.7m)
Debt / FCF = 4.26 (Net Debt 2.97b / FCF TTM 696.9m)
Total Stockholder Equity = 2.20b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.10% (Net Income 521.7m / Total Assets 6.73b)
RoE = 23.72% (Net Income TTM 521.7m / Total Stockholder Equity 2.20b)
RoCE = 16.20% (EBIT 807.4m / Capital Employed (Equity 2.20b + L.T.Debt 2.78b))
RoIC = 13.25% (NOPAT 588.0m / Invested Capital 4.44b)
WACC = 9.51% (E(10.07b)/V(13.22b) * Re(12.21%) + D(3.15b)/V(13.22b) * Rd(1.21%) * (1-Tc(0.27)))
Discount Rate = 12.21% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -5.95%
[DCF] Terminal Value 74.92% ; FCFF base≈700.8m ; Y1≈800.2m ; Y5≈1.10b
[DCF] Fair Price = 412.5 (EV 14.57b - Net Debt 2.97b = Equity 11.61b / Shares 28.1m; r=9.51% [WACC]; 5y FCF grow 16.58% → 2.90% )
EPS Correlation: 54.35 | EPS CAGR: 6.93% | SUE: -0.25 | # QB: 0
Revenue Correlation: 64.76 | Revenue CAGR: 6.60% | SUE: -0.29 | # QB: 0
EPS next Quarter (2026-06-30): EPS=4.82 | Chg7d=-0.027 | Chg30d=-0.679 | Revisions Net=-10 | Analysts=15
EPS current Year (2026-12-31): EPS=18.41 | Chg7d=-0.147 | Chg30d=-2.464 | Revisions Net=-11 | Growth EPS=-6.9% | Growth Revenue=+12.3%
EPS next Year (2027-12-31): EPS=21.30 | Chg7d=-0.178 | Chg30d=-2.351 | Revisions Net=-11 | Growth EPS=+15.7% | Growth Revenue=+4.3%
[Analyst] Revisions Ratio: -0.83 (1 Up / 11 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 7.1% (Discount Rate 12.2% - Earnings Yield 5.1%)
[Growth] Growth Spread = +12.3% (Analyst 19.4% - Implied 7.1%)